Weil Company’s Sanofi SNY Stock Holding History

Weil Company’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,300	Closed	-$60K	–	291
2019 Q3	$60K	Buy	+1,300	New	+$56.1K	0.04%	175

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Weil Company's SNY Position: Q4 2019 in Review

Weil Company sold out of Sanofi (SNY) in Q4 2019, closing a stake of 1,300 shares — an estimated $60K sold.

Weil Company first reported a position in SNY in Q3 2019 and held it in 1 quarter. The position peaked at $60K in Q3 2019. 531 funds tracked by Wall St. Rank hold SNY as of Q4 2019.

Weil Company reported no remaining Sanofi position as of Q4 2019 after selling out during the quarter.
Weil Company sold 1,300 Sanofi shares in Q4 2019, an estimated $60K.
Weil Company first reported a position in Sanofi in Q3 2019 and held it in 1 quarter.
Weil Company's Sanofi position peaked at $60K in Q3 2019.
531 funds tracked by Wall St. Rank held Sanofi as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.